-
Shorla Oncology Announces FDA Approval of TEPYLUTE® 100mg, First and Only Ready-to-Dilute Multi-Dose Vial of Thiotepa to Treat Breast and Ovarian Cancer and Commercial Launch of TEPYLUTE 15mg and 100mg Vials in the U.S.
29 Apr 2025 11:31 GMT
… pharmaceutical company, announced today that the U.S. Food and Drug … Shorla Oncology.
The American Cancer Society estimates that more … attenuated viral or bacterial vaccines to a patient … reduce the efficacy of cyclophosphamide treatment.
USE IN SPECIFIC …
-
Bria-IMT Plus Checkpoint Inhibition Is Safe and Yields Clinical Benefit in Pretreated Metastatic Breast Cancer
28 Apr 2025 22:27 GMT
… Chumsri, MD, a medical oncologist at the Mayo … the treatment regimen.
The regimen consists of intravenous cyclophosphamide at … had prior exposure to antibody-drug conjugates (ADCs; 44%), … : an allogeneic whole cell cancer vaccine. Presented at: 2025 AACR …
-
Human medicines European public assessment report (EPAR): Dazublys, trastuzumab, Status: Opinion
28 Apr 2025 10:38 GMT
… the treatment of breast and gastric cancer.
The applicant for this medicinal product … adjuvant chemotherapy with doxorubicin and cyclophosphamide in combination with paclitaxel or …
-
Arvinas Shares New Preclinical Combination Data for the PROTAC BCL6 Degrader, ARV-393, at the 2025 American Association for Cancer Research Annual Meeting
28 Apr 2025 10:45 GMT
… biotechnology company working to develop a new class of drugs … with SOC chemotherapy (rituximab, cyclophosphamide, doxorubicin, vincristine, and … foundation of lymphoma treatment, we are encouraged … cell lymphoma and promotes cancer cell survival, proliferation …
-
TRPC3 contributes to cyclophosphamide-induced cystitis progression by enhancing bladder fibrosis through activation of the TGF-β/smad pathway.
27 Apr 2025 22:48 GMT
… for this condition.
Using a cyclophosphamide-induced cystitis rat model, we … challenging condition with limited current treatment options.
Frontiers in pharmacology. 2025 …
-
The Targeted Pulse: AI Cancer Diagnosis, Breast Cancer Treatment Updates, and More
27 Apr 2025 16:17 GMT
… HER2-positive metastatic breast cancer treatment, revealed that the … Therapy Meetings, investigated posttransplant cyclophosphamide as graft-vs-host … the FDA, the design of this registrational trial has … study.
Published in Nature Medicine, the study also …
-
KEYTRUDA® (pembrolizumab) as Perioperative Treatment With Standard of Care (SOC) Adjuvant Therapy Significantly Improved Event-Free Survival Compared to SOC Alone in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
27 Apr 2025 16:10 GMT
… and Drug Administration (FDA), with a Prescription Drug User … trials studying KEYTRUDA across a wide variety of cancers and treatment … cyclophosphamide) followed by surgery and continued adjuvant treatment … of important medicines and vaccines. We aspire …
-
Benefit scheduled to help area woman with medical care
25 Apr 2025 05:40 GMT
… for Lawrence’s medical treatment for the disease … , which are drugs that inhibit or … mofetil, cyclosporine, tacrolimus, cyclophosphamide and hydroxychloroquine; and immunoglobulin … immunoglobulin, is the treatment doctors prescribed for Lawrence. …
-
88 Eflapegrastim, a Long-Acting Granulocyte Colony–Stimulating Factor, Administered the Same Day as Chemotherapy in Patients With Early-Stage Breast Cancer: Results From a Multicenter, Open-Label Study
24 Apr 2025 20:42 GMT
… with early-stage breast cancer receiving docetaxel and cyclophosphamide chemotherapy have a … dosing. In the phase 3 trials ADVANCE (NCT02643420) and RECOVER ( … (anti-infective use/hospitalization). Treatment-emergent adverse effects (TEAEs) of …
-
Allogene Therapeutics to Present Updated ALLO-316 Clinical Results in Kidney Cancer in Oral Presentation and ALPHA3 Trial-in-Progress Poster for Cema-Cel at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
23 Apr 2025 14:12 GMT
… ALLO), a clinical-stage biotechnology company pioneering the development … first-line (1L) treatment for patients with … of cyclophosphamide and fludarabine. The ALPHA3 trial is … Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy …
About
© 1995-2025